|
1
|
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
|
J Clin Invest
|
1995
|
3.47
|
|
2
|
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
|
Proc Natl Acad Sci U S A
|
1999
|
2.44
|
|
3
|
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.
|
Antimicrob Agents Chemother
|
1999
|
1.63
|
|
4
|
Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.
|
Proc Natl Acad Sci U S A
|
1986
|
1.48
|
|
5
|
The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes.
|
Clin Immunol Immunopathol
|
1982
|
1.42
|
|
6
|
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
|
Antimicrob Agents Chemother
|
2005
|
1.25
|
|
7
|
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.
|
Antimicrob Agents Chemother
|
2000
|
1.13
|
|
8
|
Induction in vitro of a primary human antiviral cytotoxic T cell response.
|
Eur J Immunol
|
1995
|
1.13
|
|
9
|
A C9 related channel forming protein in the cytoplasmic granules of human large granular lymphocytes.
|
Biosci Rep
|
1985
|
1.02
|
|
10
|
In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
|
Antimicrob Agents Chemother
|
2007
|
0.94
|
|
11
|
Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.
|
Proc Natl Acad Sci U S A
|
1988
|
0.89
|
|
12
|
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.
|
Bioorg Med Chem Lett
|
2000
|
0.84
|
|
13
|
Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.
|
J Immunol
|
1989
|
0.83
|
|
14
|
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors.
|
Bioorg Med Chem Lett
|
2001
|
0.75
|
|
15
|
Evaluation of low back pain by differential spinal block.
|
Can Anaesth Soc J
|
1968
|
0.75
|
|
16
|
Inhibition of cytolytic lymphocytes by homologous restriction factor. Lack of species restriction.
|
J Immunol
|
1991
|
0.75
|